Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Effects of Using Advanced NEUROrehabilitation TECHnologies in Upper Limb Motor Function and Capacity Recovery in People With Stroke

Key facts

Where
Fiorenzuola d'Arda, ItalySee the site

Where in Italy

  • Fiorenzuola d'Arda Hospital - AUSL PiacenzaFiorenzuola d'Arda, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Azienda Unita Sanitaria Locale di Piacenza
Trial code
NCT07698405
Record updated
22 September 2026
Original description
This study aims to evaluate the effect of a personalized technology-based rehabilitative intervention on Upper Limb (UL) motor function and capacity recovery in People with Stroke (PwS). The study is single-cohort study in which eligible participants will undergo baseline and follow-up clinical and instrumental assessments over a 4-5 week period.Read full original descriptionShow less

This study aims to evaluate the effect of a personalized technology-based rehabilitative intervention on Upper Limb (UL) motor function and capacity recovery in People with Stroke (PwS). The study is single-cohort study in which eligible participants will undergo baseline and follow-up clinical and instrumental assessments over a 4-5 week period.

The intervention consists of a personalized and specific upper limb technology-based rehabilitation programme delivered three times per week for a total of 12-15 sessions. Each session lasts approximately one hour and is integrated with conventional rehabilitation treatments.

Primary outcomes include Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT). Secondary outcomes include instrumental assessment of active range of motion and grip strength.

Inclusion: Age ≥ 18 years; First-ever unilateral ischemic or hemorrhagic stroke; Presence of upper limb motor impairment; Modified Ashworth Scale (MAS) < 3; Montreal Cognitive Assessment (MoCA) > 24; Medically stable and able to participate in an intensive rehabilitation programme; Ability to understand and follow study procedures; Written informed consent.

Exclusion: Severe and unstable medical conditions (e.g. untreated seizure, heart failure) that preclude participation in rehabilitation; Other neurological and/or psychiatric diseases; Diagnosis of severe aphasia, based on medical records, preventing participation; Bilateral hemisphere lesions; Recent and unstabilized upper limb fracture.

ClinicalTrials.gov NCT07698405